CTO and Director of ImmunoScience

Dr. Bay-Jensen has been with Nordic Bioscience since 2008 - she started as a post-doc and has since been appointed Director of ImmunoScience and Chief Technology Officer (CTO). Through hard work, inventive mentality, and leadership, she has developed novel biomarkers that support precision medicine - a journey that continues. As a researcher, she focuses primarily on biomarkers for rheumatic diseases, which she has worked on for two decades.

H-index: 58. i10-index: 180. Citations: 9708 as of March 2023.

Please don't hesitate to contact us if you have any questions or other inquiries.

Are you interested in learning more about Nordic Bioscience?
Enter your information in the form and a representative will contact you shortly.

By submitting this form you agree to our terms and conditions.